
2C-H: Difference between revisions
>Kaylee No edit summary |
>Kaylee No edit summary |
||
Line 36: | Line 36: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Phenethylamine]] |
Revision as of 21:41, 30 December 2016
2C-H | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||
Common names | 2C-H, DMPEA | ||||||||||||||
Substitutive name | 2,5-Dimethoxyphenethylamine | ||||||||||||||
Systematic name | 2-(2,5-Dimethoxyphenyl)ethanamine | ||||||||||||||
Class Membership | |||||||||||||||
Psychoactive class | Stimulant / Psychedelic | ||||||||||||||
Chemical class | Phenethylamine | ||||||||||||||
Routes of Administration | |||||||||||||||
|
|||||||||||||||
Interactions | |||||||||||||||
Summary sheet: 2C-H |
2C-H (2,5-Dimethoxyphenethylamine) is a lesser-known substituted phenethylamine that is the traditional precursor to 2C-B, 2C-C and 2C-I. It was first synthesized in 1932 by Johannes S. Buck and was later studied in the 1970s by Alexander Shulgin, who published his findings in his book PiHKAL. Shulgin lists both the dosage and duration as unknown, as 2C-H easily broken down by the MAO enzyme in the liver and is thus considered inactive. When combined with a MAOI, it is believed to have stimulant effects.
Chemistry
2C-H or 2,5-dimethoxyphenethylamine is a substituted phenethylamine featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain. 2C-H contains methoxy functional groups CH3O- attached to carbons R2 and R5 as well as a hydrogen atom attached to carbon R4 of the phenyl ring. 2C-H belongs to the 2C family of phenethylamines which contain methoxy groups on the 2 and 5 positions of the benzene ring, and is also their simplest member. It is commonly used as a precursor to other compounds of the 2C family, including 2C-B, 2C-C, 2C-I, and 2C-N.
Pharmacology
There is no record of 2C-H trials in humans, as it would likely be destroyed by monoamine oxidase enzymes before causing any significant psychoactive effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-H. However, it has been shown to have binding affinity towards 5-HT2C and 5-HT2A receptors in rats.[2]
Subjective effects
![]() |
This subjective effects section is a stub. As such, it is still in progress and may contain incomplete or wrong information. You can help by expanding or correcting it. |
Toxicity and harm potential
![]() |
This toxicity and harm potential section is a stub. As a result, it may contain incomplete or even dangerously wrong information! You can help by expanding upon or correcting it. |
The toxicity and long-term health effects of recreational 2C-H use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because 2C-H is a research chemical with very little history of human usage. Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.
It is strongly recommended that one use harm reduction practices when using this drug.
Legal issues
- Canada: As of October 31st, 2016, 2C-H is a controlled substance (Schedule III) in Canada, and is thus illegal to possess, produce and sell.[3]
- United States: As of July 9, 2012, 2C-H is a Schedule I controlled substance in the United States, under the Synthetic Drug Abuse Prevention Act of 2012.[4]
- United Kingdom: It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.[5]
See also
References
- ↑ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ↑ 2C-H BioAssay Results (PubChem) | https://pubchem.ncbi.nlm.nih.gov/compound/76632#section=BioAssay-Results
- ↑ http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php
- ↑ https://www.deadiversion.usdoj.gov/fed_regs/rules/2013/fr0104.htm
- ↑ Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted